Kenneth Olivier

Kenneth Olivier is an accomplished professional in the field of drug development, currently serving as Executive Vice President of Development at Neutrolis Inc since December 2023. In addition to this role, Kenneth has operated as a Drug Development Consultant at Olivier KOnsulting since September 2015. Prior experience includes serving as Vice President of Nonclinical Development at TScan Therapeutics from February 2020 to December 2023, Executive Director at Morphic Therapeutic from May 2018 to January 2020, and Head of Nonclinical Development at Torque Therapeutics from August 2017 to February 2018. Kenneth holds a Doctor of Philosophy (PhD) in Veterinary Biomedical and Clinical Sciences from Oklahoma State University and a Bachelor of Science (BS) in Toxicology from the University of Louisiana Monroe.